Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 45Leukemia 38Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia, Erythroblastic, Acute 14Leukemia, Myelomonocytic, Acute 13Leukemia, Monocytic, Acute 13Leukemia, Megakaryoblastic, Acute 13Congenital Abnormalities 11Myelodysplastic Syndromes 8Lymphoma 7Burkitt Lymphoma 7Anemia, Refractory, with Excess of Blasts 7Leukemia, Eosinophilic, Acute 5Myeloproliferative Disorders 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Biphenotypic, Acute 4Leukemia, Basophilic, Acute 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic-Myeloproliferative Diseases 3Neoplasm Metastasis 2Leukemia, Promyelocytic, Acute 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Down Syndrome 2Anemia, Refractory 2Sarcoma, Myeloid 1Sarcoma, Kaposi 1Sarcoma 1Recurrence 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1

Interventions

liposomal doxorubicin 1Paclitaxel 1Daunorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × AIDS-related Kaposi sarcoma × Daunorubicin × Clear all
NCT00002985 2013-02-04

Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma

Roswell Park Cancer Institute

Phase 3 Completed
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡